Malaria transmission blocking activity of Anopheles stephensi alanyl aminopeptidase N antigen formulated with MPL, CpG, and QS21 adjuvants., PMID:38968270
A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial., PMID:38649867
Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody., PMID:38086855
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults., PMID:35963275
Inhibition of Asaia in Adult Mosquitoes Causes Male-Specific Mortality and Diverse Transcriptome Changes., PMID:32429180
Strong concordance between percent inhibition in oocyst and sporozoite intensities in a Plasmodium falciparum standard membrane-feeding assay., PMID:31060594
Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection in Anopheles stephensi., PMID:31014347
Combining Monophosphoryl Lipid A (MPL), CpG Oligodeoxynucleotide (ODN), and QS-21 Adjuvants Induces Strong and Persistent Functional Antibodies and T Cell Responses against Cell-Traversal Protein for Ookinetes and Sporozoites (CelTOS) of Plasmodium falciparum in BALB/c Mice., PMID:30936155
Anopheline antiplatelet protein from mosquito saliva regulates blood feeding behavior., PMID:30816309
Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density., PMID:29914622
PfCap380 as a marker for Plasmodium falciparum oocyst development in vivo and in vitro., PMID:29609625
A male gametocyte osmiophilic body and microgamete surface protein of the rodent malaria parasite Plasmodium yoelii (PyMiGS) plays a critical role in male osmiophilic body formation and exflagellation., PMID:29316140
Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens., PMID:29041962
Cloning, characterization and transmission blocking potential of midgut carboxypeptidase A in Anopheles stephensi., PMID:28087198
Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates., PMID:27515826
Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe., PMID:27491342
"Salivary gland cellular architecture in the Asian malaria vector mosquito Anopheles stephensi"., PMID:26627194
Anopheles stephensi p38 MAPK signaling regulates innate immunity and bioenergetics during Plasmodium falciparum infection., PMID:26283222
Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum., PMID:26063320
Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum., PMID:25890243
Experimental study of the relationship between Plasmodium gametocyte density and infection success in mosquitoes; implications for the evaluation of malaria transmission-reducing interventions., PMID:25541384
Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge., PMID:25405724
Humanized HLA-DR4.RagKO.IL2RγcKO.NOD (DRAG) mice sustain the complex vertebrate life cycle of Plasmodium falciparum malaria., PMID:25266106
Molecular characterization of calreticulin from Anopheles stephensi midgut cells and functional assay of the recombinant calreticulin with Plasmodium berghei ookinetes., PMID:25150160
Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding., PMID:24421036
Comparative susceptibility of different biological forms of Anopheles stephensi to Plasmodium berghei ANKA strain., PMID:24086525
Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay., PMID:24042109
Immunisation against a serine protease inhibitor reduces intensity of Plasmodium berghei infection in mosquitoes., PMID:23872520
Molecular characterization of the carboxypeptidase B1 of Anopheles stephensi and its evaluation as a target for transmission-blocking vaccines., PMID:23569111
Reduction of malaria transmission by transgenic mosquitoes expressing an antisporozoite antibody in their salivary glands., PMID:23176559
Anopheles salivary gland proteomes from major malaria vectors., PMID:23148599
One Injection of DsRed Followed by Bites from Transgenic Mosquitoes Producing DsRed in the Saliva Elicits a High Titer of Antibody in Mice., PMID:23097619
Induction of antisporozoite antibodies by biting of transgenic Anopheles stephensi delivering malarial antigen via blood feeding., PMID:22787718
Transgenic Anopheles stephensi coexpressing single-chain antibodies resist Plasmodium falciparum development., PMID:22689959
A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity., PMID:22216279
Effect of anti-fat body antibodies on reproductive capacity of mosquito Anopheles stephensi and transmission blocking of Plasmodium vivax., PMID:21800498
Wide cross-reactivity between Anopheles gambiae and Anopheles funestus SG6 salivary proteins supports exploitation of gSG6 as a marker of human exposure to major malaria vectors in tropical Africa., PMID:21794142
A new role for an old antimicrobial: lysozyme c-1 can function to protect malaria parasites in Anopheles mosquitoes., PMID:21573077
Engineered resistance to Plasmodium falciparum development in transgenic Anopheles stephensi., PMID:21533066
The kinin receptor is expressed in the Malpighian tubule stellate cells in the mosquito Aedes aegypti (L.): a new model needed to explain ion transport?, PMID:21056665
Past, present and future research directions with Pichia anomala., PMID:20924674
Production of a transgenic mosquito expressing circumsporozoite protein, a malarial protein, in the salivary gland of Anopheles stephensi (Diptera: Culicidae)., PMID:20802540
Plasmodium yoelii: correlation of TEP1 with mosquito melanization induced by nitroquine., PMID:20599985
Cloning, expression and transmission-blocking activity of anti-PvWARP, malaria vaccine candidate, in Anopheles stephensi mysorensis., PMID:20537198
Monoclonal antibodies AC-43 and AC-29 disrupt Plasmodium vivax development in the Indian malaria vector Anopheles culicifacies (Diptera: Culicidae)., PMID:20413913
Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission in both passive and active vaccination regimens in a rodent model of malaria infection., PMID:19752035
Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25., PMID:18316385
Role of heat-labile serum factor or host complement in the inhibition of Plasmodium falciparum sporogonic stages in Anopheles stephensi by gametocyte carriers' serological factors., PMID:17645813
[Effect of anti-midgut-protein-ingredient antibodies of Anopheles stephensi on the oocysts of Plasmodium yoelii]., PMID:17366975
Plasmodium yoelii: the effect of second blood meal and anti-sporozoite antibodies on development and gene expression in the mosquito vector, Anopheles stephensi., PMID:17083935
For research use only. Not for human or drug use.
